您的位置: 首页 > 农业专利 > 详情页

Antisense oligonucleotides for the treatment of stargardt disease
专利权人:
ProQR Therapeutics II B.V.
发明人:
Yilmaz-Elis, Aliye Seda,Adamson, Peter,Dulla, Kalyana Chakravarthi,Schulkens, Iris Antoinette Ernestine
申请号:
AU2018252191
公开号:
AU2018252191A1
申请日:
2018.04.13
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The invention relates to the fields of medicine and biotechnology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Stargardt disease and/or ABCA4-associated eye disease. More in particular, the invention relates to AONs that are used in inhibiting or blocking exon 39 skipping in the human ABCA4 pre-mRNA.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充